SEC Form 4 · accession 0001209191-17-028285
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Munshi
Officer — President and CEO · Director
Period of report
Apr 26, 2017
Accepted (ET)
Apr 27, 2017 · 8:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2017 | J | 625 | $1.24 | A | 1,875 | D | |
| Common Stock | Apr 26, 2017 | P | 50,000 | $1.41 | A | 51,875 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were acquired pursuant to the 2009 Arena Employee Stock Purchase Plan.